Cases Involve Stomach, Colon, Rectal, Bladder, Kidney, And Pancreatic Cancers Diagnosed After Taking Zantac

 

(Posted by Tom Lamb at DrugInjuryWatch.com)

 

Zantac cancer lawsuits are being filed for patients diagnosed with certain types of cancer after using Zantac (ranitidine) for heartburn associated with acid indigestion and sour stomach.

This is because Zantac contains NDMA (nitrosamine impurity called N-nitrosodimethylamine), a probable human carcinogen. This "new" fact was the subject of a September 13, 2019 FDA Press Announcement, "Statement alerting patients and health care professionals of NDMA found in samples of ranitidine".

Ranitidine is the active ingredient in Zantac — both brand name prescription Zantac as well as over the counter, or OTC, Zantac which can be bought without a doctor's prescription at any pharmacy.

Since Zantac has been FDA-approved in the US for many years and used a countless number of times by millions of patients, this Zantac cancers FDA warning came as a shock for most of us.

According to medical research, some of the cancers associated with Zantac use due to NDMA exposure include:

• Stomach cancer
• Colon cancer
• Rectal cancer
• Bladder cancer
• Kidney cancer
• Pancreatic cancer

Since the September 2019 Zantac NDMA FDA announcement, some patients diagnosed with these cancers have contacted drug injury lawyers and, in turn, Zantac lawsuits have been filed against the pharmaceutical companies responsible for prescription Zantac and over the counter Zantac.

__________________________________________________________________

Zantac

Free Case Evaluation

Strictly Confidential, No Obligation.

__________________________________________________________________

 

As regards the medical research mentioned above, here are a couple of items:

1. A 2011 medical study looking at NDMA exposure concluded that NDMA ingestion, e.g., Zantac pills use, was significantly associated with an increased risk for gastrointestinal cancers including rectal cancer. See: Loh et al, "N-nitroso compounds and cancer incidence: the European Prospective Investigation into Cancer and Nutrition (EPIC)—Norfolk Study", 93 Am J CLIN NUTR. 1053-61 (2011).  [Full text of this article in PDF format]
2. A 2004 medical study concluded that the recent use of Zantac was also related to an increased risk of bladder cancer. See: Michaud et al, "Peptic ulcer disease and the risk of bladder cancer in a prospective study of male health professionals", 13 CANCER EPIDEMIOL BIOMARKERS PREV. 2, 250-254 (2004).  [Full text of this article in PDF format]

Our law firm is currently investigating possible Zantac cancer lawsuits for personal injury and wrongful death cases. Please feel free to contact us if you want help evaluating a Zantac case. This service is free, confidential, and there is no obligation.

DrugInjuryLaw.com: Medical & Legal Information About Drug Side Effects  (All website content by attorney Tom Lamb)

Drug Injury Case Evaluation – Free. Confidential. No Obligation.  (Case review is done by attorney Tom Lamb)